AIAI Holdings Corporation Class A Common Stock

AIAI NASDAQ: AIAI is pursuing an acquisition-led strategy that combines retained management teams with proprietary artificial intelligence technology, CEO Todd Furniss said during a company presentation. The company does not intend to sell software or services to outside customers, Furniss said, but instead plans to deploy its technology across businesses it acquires.

DALLAS, TX / ACCESS Newswire / October 14, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai²" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that Chief Executive Officer Todd Furniss will present at the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. AIAI Holdings is scheduled to present on Wednesday, October 21, 2026 at 02:30 PM PT.

DALLAS, TX / ACCESS Newswire / October 8, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai²" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced that certain entities controlled by the family of John P. Rochon have acquired approximately $26.8 million of Ai² shares through privately negotiated transactions with an existing large stockholder.

TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc . (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a clinical intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Dr. Joseph Geraci, Founder and Chief Scientific and Technical Officer, will participate in the H.C. Wainwright 3rd Annual AI Based Drug Discovery and Development Virtual Conference, taking place October 8–9, 2026.

Capital Contribution Requires no Consideration to be Paid DALLAS, TX / ACCESS Newswire / September 18, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its affiliated entity, Messier 42 LLC ("M42"), has agreed to contribute to the capital of the Company a controlling position in the entity holding M42's marketing agreement for the sale of military equipment (the "Teaming Agreement"). Under this arrangement, 100% of the revenue and EBITDA generated by the M42 entity which holds the Teaming Agreement will be consolidated on the Company's financial statements and reported by the Company and the Company will distribute approximately 50% of the resulting Free Cash Flow to M42.

Constellation Brings Dôr's Retail Intelligence Architecture to Healthcare Connects Clinical, Scheduling, Call-Center and Staffing Data to Predict Care Needs, Optimize Provider Capacity and Improve Patient Access DALLAS, TX / ACCESS Newswire / September 17, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance announced today that its portfolio company, Constellation Network, through Dôr Technologies, has launched Dôr Patient Journey, a new healthcare intelligence platform. Developed in collaboration with Proactive MD, the platform is actively deployed within Proactive MD's care environment.

DALLAS, TX / ACCESS Newswire / September 11, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance announced today that it has entered into amendments to its existing lock-up agreements entered into in connection with the Company's direct listing with holders of the Company's outstanding shares of Class A Common Stock. The list of those signing the amendment includes the Company's founder and Chairman, other members of the Company's board of directors, members of management and a majority of its largest stockholders.

With Projected $250M of Annual Free Cash Flow Post Closing DALLAS, TX / ACCESS Newswire / September 3, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, announced that the Company has entered into a letter of intent with its affiliated entity, Messier 42 LLC ("M42"), to acquire a controlling interest in one of M42's businesses with operations in the defense industry. M42 projects that this business is expected to produce $250 million in Free Cash Flow during the 12 months following the closing.